Germany· DE-A57-a0c461f373c5f7ab
Parecoxib Chenpon
A parecoxib product containing parecoxib, registered in Germany by Chenpon De Gmbh. The same ATC class is registered in 13 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Parecoxib is registered in 13 of 19 countries.
Countries holding a registration under ATC M01AH04 (parecoxib), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 7 of them publish a price we can compare per daily dose
Parecoxib · ATC M01AH04
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Parecoxib
- Manufacturer
- Chenpon De Gmbh
- Country
- Germany (DE)
- ATC code
- M01AH04
- ATC class
- Parecoxib
- Defined daily dose
- 40 mg, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Parecoxib in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandDynastatPfizer Limited
- United KingdomDynastat 40mg powder and solvent for solution for injection vialsPfizer Ltd
- IrelandDynastat 40 mg Powder and solvent for solution for injectionPfizer Europe MA EEIG
- SwedenDynastat 40 mg Pulver och vätska till injektionsvätska, lösningPfizer Europe MA EEIG
- NetherlandsDynastat 40 mg, poeder en oplosmiddel voor oplossing voor injectiePfizer Europe MA EEIG
- CzechiaDYNASTATPfizer Europe MA EEIG, Bruxelles
- NorwayDynastatPfizer Europe MA EEIG (1)
- IcelandDynastatPfizer Europe MA EEIG*
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Denmark · Parecoxib Macure, Parecoxib Noridem
- Finland · Parecoxib Macure
- United Kingdom (Northern Ireland) · Parecoxib Aspire Pharma, Parecoxib Noridem Enterprises
- Greece · Coxidem, Pyrixip
- Ireland · Parecoxib Noridem Enterprises Limited
- Iceland · Dynastat, Parecoxib Macure
- Liechtenstein · Dynastat
- Malta · Parecoxib Noridem
- Netherlands · Parecoxib Chenpon, Parecoxib Seacross
- Norway · Dynastat, Parecoxib Macure
- Portugal · Parecoxib Noridem, Pyrixip
- Romania · Parecoxib Noridem
- Sweden · Parecoxib Macure, Parecoxib Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/40cb38a8-2b53-4c35-b593-32f3c0228fab GET /v1/drugs/40cb38a8-2b53-4c35-b593-32f3c0228fab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use ,Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Parecoxib",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about parecoxib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.